An unusual case of epidermolysis bullosa complicated by persistent oligoarticular juvenile idiopathic arthritis; lessons to be learned

Pediatric Rheumatology

Volumn 9, Issue , 2011, Pages

  Maritsi, Despoina ^a   Martinez, Anna E ^b   Mellerio, Jemima E ^b   Eleftheriou, Despina ^a   Pilkington, Clarissa A ^a  

^a Rheumatology Department   (United Kingdom)

^b Dermatology Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE HEXACETONIDE;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; DIET RESTRICTION; ENTERITIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RARE DISEASE; SCHOOL CHILD; SKIN BIOPSY;

EID: 79959551861     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-9-13     Document Type: Article

References (6)

1. Culpepper TL. Anaesthetic implications in epidermolysis bullosa dystrophica. AANA J 2001, 69:114-8.
2. Fine JD, Johnson LB, Weiner M, Suchindran C. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr 2008, 152:276-80. 10.1016/j.jpeds.2007.06.039, 18206702.
3. Atherton DJ, Mellerio JE, Denyer. Epidermolysis bullosa. Textbook of Paediatric Dermatology 2006, II, chapter 16:1291-1304. Blackwell Publishing, Harper JI, Oranje A, Prose N.
4. Caprilli R, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations Gut. 2006, 55(Suppl I):i36-i58.
5. Rosh JR, et al. Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn's Disease. Am J Gastroenterol 2009, 104:3042-9. 10.1038/ajg.2009.493, 19724267.
6. Remington J, Chen M, Burnett J, Woodley DT. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun 2008, 10:195-205.